On July 12, 2021, WDpharma received the Notice of Approval fo≥ r Drug Clinical Trial from t÷ ©₩he National Medical Products Administr ♦✘ation, and the WD-160"≥3 project has entered into Phase II cli∏ nical trials.
Tel：86-021-68599718
E-mail：WDpharma@wdpharma.com
Address：720 Cailun Road, Suite 403,Bu™§♦∏ilding 1, Zhangiiang Hi-Tech×≤↓ Park, Pudong New Distr®¥ict, Shanghai, China（R&D→±™$ Center）
Zip code：201203
